BioCatalystWatch
KLRAWorkspace / KLRA / OverviewCompany library
Kailera Therapeutics, Inc. logo

Kailera Therapeutics, Inc.

Kailera Therapeutics, Inc. (KLRA)

Website

Price
Market cap
Next catalyst2H 2026KAI-4729 · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Peptide

GLP-1 receptor × GIP receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Peptide

GLP-1 receptor × GIP receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

Small molecule

GLP-1 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

KAI-4729

GLP-1 receptor × GIP receptor × Glucagon receptor

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

KAI-4729

GLP-1 receptor × GIP receptor × Glucagon receptor

Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

  • Timing and evidence

Peptide

GLP-1 receptor × GIP receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

Peptide

GLP-1 receptor × GIP receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

Small molecule

GLP-1 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

Peptide

GLP-1 receptor × GIP receptor

PreINDP1P2P3FilingApproved

Small molecule

GLP-1 receptor

PreINDP1P2P3FilingApproved
KAI-4729

GLP-1 receptor × GIP receptor × Glucagon receptor

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



Reported shares and borrowings

Source and basis

Ownership and institutions

Market Reaction / Supply Context

Market Structure

KLRA PR & News

PR & News

KLRA SEC archive